LicianPro

BCAX holders · CITADEL ADVISORS LLC 13F · BCAX stock

CITADEL ADVISORS LLC Bicara Therapeutics Inc. Common Stock (BCAX) 13F holding

CITADEL ADVISORS LLC reported 1,659,342 BCAX shares valued at $33.0M as of 2026-03-31. Share lines from that 13F summed, options excluded; value is the 13F-reported market value in US dollars, as reported on Form 13F, not a live feed.

This is the newest BCAX 13F on file for this filer CIK, and it is older than the quarter ended 2026-06-30. It is kept for history and left out of the BCAX holders table.

BCAX reports from CITADEL ADVISORS LLC · SEC Form 13F
ReportSharesValueClass
2026-03-311,659,342$33.0MCOM
2025-12-31772,258$13.0MCOM
2025-06-30221,516$2.1MCOM

Not investment advice. Holdings as reported on Form 13F; EDGAR is the official record.